首頁 > 市場調查報告書 > 醫療設備

生物材料

市場調查報告書

商品編碼

1733440

2026-2032年醫療塑膠擠出市場（按類型、應用和地區）

Medical Plastics Extrusion Market By Type (Medical Tubing), Application (Hospital, Clinic), & Region For 2026-2032

出版日期: 2025年05月13日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

醫療塑膠擠出市場評估-2026-2032

由於對高性能、可靠醫療設備和零件的需求不斷增加，醫療塑膠擠壓市場正在成長。塑膠擠壓成本低，且能夠創造複雜的形狀和設計，使其成為生產醫用管、導管和其他關鍵部件的理想選擇，預計到 2024 年市場規模將超過 9.0399 億美元，到 2032 年將達到 12.2494 億美元。

為了最大限度地減少醫療環境中的感染和交叉污染，人們越來越傾向於使用一次性醫療器械，這推動了對醫用塑膠擠壓的需求。注射器、靜脈輸液管和藥物輸送系統因其衛生優勢而越來越受歡迎。隨著全球醫療保健系統尋求更安全、更經濟的替代品，醫用塑膠提供了一種耐用且用途廣泛的選擇，推動市場在 2026 年至 2032 年期間以 4.27% 的複合年成長率成長。

醫療塑膠擠壓市場定義/概述

醫用塑膠擠出是一種將塑膠材料形成連續型材以生產各種醫療設備和零件的專門製造方法。將 PVC、聚乙烯和聚丙烯等醫用級塑膠熔化並透過專門設計的晶粒壓制，以形成管材、導管和鞘套等精確的形狀。擠壓方法具有高精度和一致性，這對於公差要求嚴格的醫療應用和必須符合嚴格安全和監管標準的產品至關重要。

它通常用於製造各種醫療設備，包括導管、管材和手術器械。該技術涉及將高品質聚合物熔化和模塑成符合嚴格醫療要求的精確、可客製化的形式。

由於對微創治療和改進的醫療設備的需求不斷增加，預計醫療塑膠擠壓的使用將會成長。醫療保健技術的進步正在推動對能夠滿足醫療應用嚴格要求的高性能、生物相容性塑膠的需求。新型聚合物材料，特別是生物可吸收聚合物的開發，將提高擠壓技術的能力，從而生產出在達到目的後能夠安全溶解在體內的設備。

微創手術需求的不斷成長是否會推動醫療塑膠擠壓市場的發展？

醫療塑膠擠壓市場正在迅速擴張，主要受微創手術需求不斷成長的推動。這一發展正在極大地改變醫療保健行業，並為醫療塑膠擠壓製造商提供了巨大的前景。微創手術的日益成長的趨勢是醫療塑膠擠壓行業的主要推動力。根據美國疾病管制與預防中心（CDC）國家健康統計報告，2006年至2018年間，美國門診手術就診人次增加了32.8%，從1,190萬人次增至1,580萬人次。

《美國醫學會雜誌》（JAMA）發表的一項研究發現，與開放性手術相比，微創手術平均可減少住院時間2.4天。較短的恢復時間將影響病患的偏好和醫院的採用。此外，對導管手術的需求也在不斷成長，這類手術通常涉及醫用塑膠的擠壓。根據美國心臟協會統計，美國每年進行約一百萬例心導管插入術。

高材料成本會阻礙醫療塑膠擠出市場嗎？

材料成本上升可能是醫療塑膠擠壓市場擴張的一大障礙。聚氯乙烯(PVC)、聚乙烯和聚丙烯等醫用塑膠通常成本較高，因為它們必須遵守嚴格的監管要求以確保安全性和生物相容性。這些塑膠必須符合較高的醫療標準，因此生產成本很高。因此，生產商將努力滿足對高品質、低成本醫療用品的需求，同時保持獲利。

材料成本的上升可能會限制生產導管、管材和其他醫療保健設備等複雜醫療部件所需的先進擠壓技術的使用。規模較小的製造商可能難以承擔優質原料帶來的成本增加，並可能失去市場競爭力。這些高成本也可能轉嫁給醫療保健提供者，從而增加醫療設備的價格並降低患者的負擔能力。

The medical plastics extrusion market is rising in response to the growing demand for high-performance, dependable medical devices and components. Plastic extrusion is a low-cost procedure that allows for the creation of complicated shapes and designs making it perfect for producing medical tubing, catheters, and other vital components by enabling the market to surpass a revenue of USD 903.99 Million valued in 2024 and reach a valuation of around USD 1224.94 Million by 2032.

The trend toward single-use medical devices to minimize infections and cross-contamination in healthcare environments drives up demand for medical plastics extrusion. Syringes, IV tubes, and drug delivery systems are becoming more popular due to their sanitary benefits. As healthcare systems around the world seek safer and more economical alternatives, medical plastics offer a durable and versatile option by enabling the market to grow at a CAGR of 4.27 % from 2026 to 2032.

Medical Plastics Extrusion Market: Definition/ Overview

Medical plastic extrusion is a specialized manufacturing method that shapes plastic materials into continuous profiles to create a variety of medical devices and components. Medical-grade plastics such as PVC, polyethylene, and polypropylene are melted and pressed through a specially designed die to make precise geometries such as tubes, catheters, and sheaths. The extrusion method provides high precision and consistency which is crucial for medical applications with tight tolerances and products that must fulfill demanding safety and regulatory criteria.

It is commonly used in the manufacture of a variety of medical devices such as catheters, tubing, and surgical tools. The technique entails melting and sculpting high-quality polymers into precise, customizable shapes that meet strict medical requirements.

The use of medical plastic extrusion is predicted to grow in response to increased demand for minimally invasive treatments and improved medical gadgets. As healthcare technologies advance, there is a growing demand for high-performance, biocompatible plastics that can withstand the harsh demands of medical applications. The development of novel polymer materials, especially bioresorbable polymers, is likely to improve the capabilities of extrusion technologies allowing the manufacturing of devices that can safely dissolve within the body once they have served their purpose.

Will the Rising Demand for Minimally Invasive Procedures Drive the Medical Plastics Extrusion Market?

The medical plastics extrusion market is expanding rapidly driven mostly by rising demand for minimally invasive procedures. This development is altering the healthcare industry presenting significant prospects for medical plastic extruders. The growing inclination for minimally invasive procedures is a major driver for the medical plastics extrusion industry as evidenced by compelling statistics. According to the Centers for Disease Control and Prevention's (CDC) National Health Statistics Reports, the number of ambulatory surgery visits in the United States increased by 32.8% between 2006 and 2018, from 11.9 million to 15.8 million.

A study published in the Journal of the American Medical Association (JAMA) discovered that minimally invasive procedures cut hospital stays by an average of 2.4 days when compared to open surgeries. This shorter recuperation time influences patient preferences and hospital adoption. The need for catheter-based procedures which frequently involve extruded medical plastics is also increasing. According to the American Heart Association, there are roughly 1 million cardiac catheterizations conducted in the United States each year.

Will the High Material Costs Hamper the Medical Plastics Extrusion Market?

High material costs may constitute a substantial barrier to the expansion of the medical plastics extrusion market. Medical-grade plastics such as polyvinyl chloride (PVC), polyethylene, and polypropylene are frequently costly due to the stringent regulatory requirements they must follow to ensure safety and biocompatibility. These plastics must meet high medical standards which increases production costs. As a result, producers may struggle to remain profitable while meeting demand for high-quality, low-cost medical items.

Rising material costs may limit the usage of advanced extrusion technologies which are required for the production of complicated medical components such as catheters, tubing, and other healthcare devices. Smaller manufacturers may struggle to absorb the increased costs associated with premium raw materials resulting in lost market competitiveness. These high expenses may also be passed on to healthcare providers, thereby raising the price of medical devices and reducing patient affordability.

Category-Wise Acumens

Will Rising Demand for Intravenous Medication Drive Growth in the Type Segment?

The medical tubing segment is predicted to experience the greatest increase in the medical plastics extrusion market during the forecasted period. The growing use of catheters and other medical equipment needs flexible, long-lasting tubing which is driving this increase. Furthermore, the increased prevalence of chronic diseases and an aging population are driving up demand for various medical equipment, accelerating the growth of the medical tubing segment.

Medical tubing is essential in IV administration because it allows fluids, nutrients, and drugs to be delivered safely and efficiently directly into the bloodstream. The growing use of IV therapies in hospitals and at home has created a substantial need for dependable and flexible medical tubing. Furthermore, advances in plastic materials such as the creation of PVC alternatives and antimicrobial coatings have improved the adaptability and safety of tubing for a wide range of medical uses.

Will the Increasing Use of Extruded Plastics Drive the Application Segment?

Hospitals, clinics, and other healthcare facilities make up the application sector of the medical plastics extrusion market. Hospitals are predicted to enjoy the most substantial growth over the projection period. The increasing demand for medical devices and consumables such as needle and syringe caps, tubing, catheters, and other extruded plastic components is a major driver of this growth. These products are essential for daily operations in hospitals where a high number of medical procedures and patient care activities occur.

The growing need for high-quality healthcare services is encouraging the use of modern medical technologies in hospitals such as extruded plastic components. These plastics have high resilience and flexibility, and they are simple to clean and sterilize making them perfect for usage in a variety of medical environments where hygiene and patient safety are critical. The growing emphasis on infection control and patient safety combined with rising healthcare spending in many places is likely to drive up demand for extruded plastic goods in hospitals positioning this industry for significant growth in the future years.

Country/Region-wise Acumens

Will Growing Healthcare Infrastructure Drive the Market in the Asia Pacific Region?

The Asia Pacific region is expected to become the dominating market for medical plastics extrusion owing to its rapidly increasing healthcare infrastructure. This expansion is especially notable in emerging markets such as China, India, and Southeast Asian countries.

The growing healthcare infrastructure in the Asia Pacific region is a key driver of the medical plastics extrusion market as evidenced by compelling statistics. According to the World Health Organization (WHO), healthcare spending in the Western Pacific Region which encompasses much of East Asia, rose from 6.4% of GDP in 2000 to 6.9% in 2018.

The region's aging population and increased chronic disease prevalence are also driving growth in the medical plastics extrusion market. The United Nations predicts that the number of persons aged 65 and up in Asia will rise from 395 million in 2020 to 954 million by 2050. Furthermore, the International Diabetes Federation predicts that the number of adults with diabetes in Southeast Asia will increase from 88 million in 2019 to 153 million by 2045. These demographic transitions and health trends drive demand for different medical equipment including catheters, tubing, and drug delivery systems which frequently use extruded medical plastics.

Will Advanced Technical Specification Drive the Market in the North American Region?

North America is predicted to be the fastest-growing region in the medical plastics extrusion market owing to its sophisticated technical specifications and high-quality standards. This rapid expansion is being driven by the region's strong healthcare infrastructure, major R&D investments, and rising demand for novel medical devices. Advanced technical criteria are propelling the medical plastics extrusion market in North America. As of 2021, the United States Food and Drug Administration (FDA) reported 6,954 registered medical device manufacturing establishments, many of which used advanced plastic extrusion processes.

The National Institutes of Health (NIH) budget for medical research reached USD 41.7 Billion in 2020, promoting breakthroughs that frequently result in new medical devices requiring complex plastic components. Furthermore, the US Bureau of Labor Statistics predicts a 5% increase in job opportunities for medical scientists from 2019 to 2029 faster than the average for all occupations reflecting continued research and development in the sector. The drive of downsizing in medical equipment with some components having dimensions as small as 0.10 mm, tests the limits of plastic extrusion technology.

Competitive Landscape

The Medical Plastics Extrusion Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the medical plastics extrusion market include:

GSH Industries

Nenplas Ltd

Saint Gobain

Atlantis Plastics, Inc.

Keller Plastics, Inc.

China Plastic Extrusion Ltd

Vesta

Teel Plastic

3M

Biomerics

In November 2023, Davis-Standard announced in November 2023 that it would acquire the Extrusion Technology Group (ETG) from entities controlled by Dutch investor Nimbus. This acquisition aligns with Davis-Standard's commitment to providing top-tier extrusion equipment and converting systems, as well as comprehensive aftermarket support.

In April 2023, Wellspect HealthCare announced a significant development in its product line when the company introduced bio-attributed raw materials into one of its offerings, specifically the LoFric Elle female urinary catheter. This is significant in an industry that has traditionally relied on fossil-based plastics, signaling a significant step forward for medical device manufacturers who prioritize sustainable and bio-sourced materials.

1 INTRODUCTION OF GLOBAL MEDICAL PLASTICS EXTRUSION MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL MEDICAL PLASTICS EXTRUSION MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL MEDICAL PLASTICS EXTRUSION MARKET, BY TYPE

5.1 Overview
5.2 Medical Tubing
5.3 Other

6 GLOBAL MEDICAL PLASTICS EXTRUSION MARKET, BY APPLICATION

6.1 Overview
6.2 Hospital
6.3 Clinic
6.4 Other

7 GLOBAL MEDICAL PLASTICS EXTRUSION MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East and Africa

8 GLOBAL MEDICAL PLASTICS EXTRUSION MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 Vesta
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 Vention Medical
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 Putnam Plastics
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 Pexco
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 Raumedic
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 Fluortek
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 VistaMed
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 Teel Plastics
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 Biomerics
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
9.10 A.P. Extrusion
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments
9.11 3M
- 9.11.1 Overview
- 9.11.2 Financial Performance
- 9.11.3 Product Outlook
- 9.11.4 Key Developments
9.12 GSH Industries
- 9.12.1 Overview
- 9.12.2 Financial Performance
- 9.12.3 Product Outlook
- 9.12.4 Key Developments
9.13 Nenplas Ltd
- 9.13.1 Overview
- 9.13.2 Financial Performance
- 9.13.3 Product Outlook
- 9.13.4 Key Developments
9.14 Saint Gobain
- 9.14.1 Overview
- 9.14.2 Financial Performance
- 9.14.3 Product Outlook
- 9.14.4 Key Developments
9.15 Atlantis Plastics, Inc.
- 9.15.1 Overview
- 9.15.2 Financial Performance
- 9.15.3 Product Outlook
- 9.15.4 Key Developments
9.16 Keller Plastics, Inc.
- 9.16.1 Overview
- 9.16.2 Financial Performance
- 9.16.3 Product Outlook
- 9.16.4 Key Developments
9.17 China Plastic Extrusion Ltd
- 9.17.1 Overview
- 9.17.2 Financial Performance
- 9.17.3 Product Outlook
- 9.17.4 Key Developments